BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Oravax Pages on BioPortfolio:

BioPortfolio the biotechnology, pharmaceutical, life science and ...
Recent Search Terms used to find this page: oravax | Oravax | Oravax | oravax | oravax | Peptide Therapeutics Cambridge | Oravax | Oravax | oravax vaccine ...
http://www.bioportfolio.com/biocorporate/7849-OraVax_Incorpo...

BioPortfolio - OraVax Incorporated - Profile
View the current OraVax Incorporated Page on BioPortfolio.com ... OraVax is engaged in the discovery, development and commercialization of vaccine and ...
http://www.bioportfolio.com/biocorporate/7849-OraVax+Incorpo...

Results from other life science and pharmaceutical sites:

BioSpace - OraVax, Inc. News, Search Jobs, Events
Company Profile. OraVax, Inc. 38 Sidney Street Cambridge Massachusetts 02139 U.S.A.. Phone: 617-494-1339 Fax: 617-494-1741. SEARCH JOBS. Industry ...
http://www.biospace.com/company_profile.aspx?CompanyId=1467...

Welcome to Acambis
Sanofi Pasteur acquisition of Acambis.
http://www.acambis.com/...

Intranasal Antibody Prophylaxis for Protection against Viral Disease
Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. ... E-mail: rweltzin/at/oravax.com. Small right arrow pointing to: ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC100244/...

CDC - Strengthening National Preparedness for Smallpox: an Update
OraVax will coordinate full clinical testing of the vaccine and submit a licensing ... The agreement allows OraVax to produce additional vaccine for
other ...
http://www.cdc.gov/ncidod/EID/vol7no1/leduc.htm...

Safety and Immunogenicity of Increasing Doses of a Clostridium ...
The final product passed safety tests developed at OraVax (Cambridge, Mass.) for mouse toxicity (0.5-mg intraperitoneal dose) and cytotoxicity (up to 0.25 ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC97978/...

Research Update
into an agreement with OraVax (Cambridge, ... OraVax will coordinate full clinical testing of the vac- ... produced by OraVax), which create a localized
...
http://www.cdc.gov/ncidod/EID/vol7no1/pdfs/luduc.pdf...

Rectal and Intranasal Immunizations with Recombinant Urease Induce ...
Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-1741. E-mail: hkleanth/at/oravax.com. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=10...

TYPES list archives
Confluence for typed terms oravax!garrel@wrath.cs.cornell.edu (Garrel Pottinger) .... Descriptions, Excluded Middle, and Constructions oravax!eurylochus. ...
http://www.seas.upenn.edu/~sweirich/types/archive/1989/...

Serum Antitoxin Antibodies Mediate Systemic and Mucosal Protection ...
Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. ..... or rabbit anti-hamster IgA (prepared at OraVax, Inc., with hamster colostral IgA as
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC96351/...

Targeted delivery of antigen to hamster nasal lymphoid tissue with ...
OraVax, Inc., Cambridge, Massachusetts 02139, USA. pgiannas@oravax.com. Small right arrow pointing to: This article has been cited by other articles in PMC.
...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?renderty...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.